Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Equity Ratio (2016 - 2026)

Pharma-Bio Serv's Equity Ratio history spans 16 years, with the latest figure at 0.76 for Q1 2026.

  • For Q1 2026, Equity Ratio rose 1.28% year-over-year to 0.76; the TTM value through Jan 2026 reached 0.76, up 1.28%, while the annual FY2025 figure was 0.87, 3.66% up from the prior year.
  • Equity Ratio reached 0.76 in Q1 2026 per PBSV's latest filing, down from 0.87 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.88 in Q3 2025 to a low of 0.74 in Q1 2024.
  • Average Equity Ratio over 5 years is 0.81, with a median of 0.8 recorded in 2023.
  • Peak YoY movement for Equity Ratio: grew 11.99% in 2022, then fell 6.04% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 0.8 in 2022, then grew by 1.06% to 0.81 in 2023, then rose by 3.89% to 0.84 in 2024, then increased by 3.66% to 0.87 in 2025, then fell by 13.4% to 0.76 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Equity Ratio are 0.76 (Q1 2026), 0.87 (Q4 2025), and 0.88 (Q3 2025).